Neoplasms

Neoplasms

Overview

This study focuses on Neoplasms as part of the NUR 324 Pathophysiology and Pharmacology course, which explores the complex characteristics, diverse types, and various treatment modalities of cancer, a leading health concern globally.

Learning Objectives

  • Distinguish between benign and malignant cells based on various histopathological and clinical criteria.

  • Describe the process of anaplasia, including its clinical significance and implications for prognosis.

  • Discuss the concept of metastatic spread, including mechanisms, pathways, and sites of metastasis commonly affected.

  • Identify triggers that may lead to the transformation of normal cells into malignant cells and understand the role of environmental factors and genetic predisposition.

What is Cancer?




Cancer is defined as a "disease of genomic alterations."It encompasses over 100 distinct diseases characterized by uncontrolled growth of anaplastic cells that invade surrounding tissues and can metastasize to distant sites.Cancer arises from mutations in a cell's genes, resulting in genomic instability, which promotes tumorigenesis and inflammation.The term "Neoplasia" refers to new growth or tumor, named according to its cell origin, and can either be benign (non-cancerous) or malignant (cancerous).

Types of Cancer

Solid Tumors

  • Carcinoma: Originates in epithelial tissue. Carcinomas can be further sub-divided:

    • Adenocarcinoma: Originates in glandular tissue; common examples include lung cancer (small cell lung cancer) and colon cancer.

  • Sarcoma: Arises from connective or supportive tissues, affecting bones, muscles, fat, and blood vessels.

Hematologic Malignancies

Blood cancers, referred to as liquid tumors, include:

  • Leukemia: Subtypes include Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Chronic Lymphocytic Leukemia (CLL).

  • Lymphoma: Encompassing Hodgkin lymphoma, Non-Hodgkin lymphoma, multiple myeloma, and myelodysplastic syndrome, affecting lymphatic and hematopoietic systems.

Carcinogens

Types:

  • Physical Carcinogens: Include ionizing radiation (such as X-rays) and ultraviolet radiation from sunlight, contributing to skin cancers like melanoma.

  • Chemical Carcinogens: Compounds such as asbestos (linked to mesothelioma), arsenic, and benzene (linked to leukemia), along with insecticides and tobacco smoke, are well-documented carcinogens.

  • Biological Carcinogens: Viruses and bacteria can contribute to cancer risk, including Human Papillomavirus (HPV) associated with cervical cancer, Human Immunodeficiency Virus (HIV) which may lead to Kaposi's sarcoma, retroviruses, and Helicobacter pylori, linked to gastric cancer.

Other Cancer Causes

  • Host Factors: These include genetics (e.g., hereditary cancer syndromes), obesity (associated with various cancers), aging, and lifestyle choices such as diet and exercise.

  • Environmental Factors: Environmental pollution (e.g., air and water quality), smoking, alcohol consumption, and poor nutritional status can contribute significantly to cancer risk.

  • Occupational Exposures: Certain occupations may expose individuals to carcinogenic materials, increasing their risk for specific cancers (e.g., coal mining and lung cancer).

Cellular Characteristics

Normal Cell Growth

Normal cells are well-differentiated with controlled slow growth, uniform shape, encapsulated boundaries, and they undergo programmed cell death (apoptosis) when necessary.

Malignant Cells

Malignant cells are poorly differentiated, demonstrate abnormal and uncontrolled growth patterns, invade nearby tissues, and possess immortality due to their ability to evade apoptosis.

Factors Increasing Malignancy Development

Factors such as genomic instability, tumor-promoting inflammation, unlocking phenotypic plasticity, nonmutational epigenetic reprogramming, polymorphic microbiomes, and a significant presence of senescent cells contribute to the development and progression of malignancies.

Mutations in Regulatory Cells

  • Proto-oncogenes: These are normal genes that, when mutated, become oncogenes, facilitating uncontrolled cellular growth and division.

  • Tumor Suppressor Genes: These genes code for proteins that inhibit cellular division and promote apoptosis; mutations can lead to unchecked cellular proliferation. Notable examples include BRCA1 and BRCA2, linked to breast and ovarian cancers.

  • DNA Repair Genes: Responsible for correcting DNA damage; mutations in these genes can lead to cancer formation due to uncorrected genetic errors.

  • Chromosome Translocation: This genetic alteration involves the exchange of chromosome segments, notably exemplified by the Philadelphia chromosome associated with Chronic Myeloid Leukemia (CML).

Inflammatory Conditions Associated with Cancer Formation

Certain chronic inflammatory conditions are correlated with specific cancers; for example, mesothelioma is strongly associated with asbestos exposure, while chronic hepatitis can predispose individuals to liver cancer.

Stages of Carcinogenesis

The process of carcinogenesis encompasses multiple stages that involve accumulated genetic mutations, activation of oncogenes, inactivation of tumor suppressor genes, leading to unregulated cell proliferation, development of cancerous neoplasm, and potential metastasis to other body sites.

Characteristics of Cancer Cells

Features such as pleomorphism, hyperchromatism, genetic polymorphism, and abnormal chromosome arrangements, including translocations and amplifications, are indicative of cancer cells and their aggressive nature.

Benign versus Malignant Cells

Benign Cells

  • Well-differentiated with a controlled growth pattern, cohesive structure and maintained apoptosis capability, typically not invasive.

Malignant Cells

  • Poorly differentiated cells characterized by uncontrolled growth and invasive properties, leading to extensive tissue damage.

Cellular Differentiation and Grading

Grading of cancer cells reflects how closely they resemble normal cells, ranging from grade 1 (well-differentiated) to grade 4 (undifferentiated), with anaplasia representing a total lack of differentiation, impacting treatment decisions and prognosis.

Metastasis

Metastasis is defined as the spread of cancer cells from the original tumor site to distant tissues and organs via the bloodstream or lymphatic system. This spread can lead to various symptomatologies depending on the organs involved, significantly complicating treatment.

Clinical Manifestations of Cancer


Common symptoms include anorexia/cachexia, abnormal bleeding, immunosuppression increasing susceptibility to infections, significant weight loss, persistent fatigue, pain due to tumor pressure, and sleep disturbances which can significantly affect quality of life.Paraneoplastic syndromes may also present as indirect effects of cancer, presenting unique sets of symptoms based on distant organ impact.

Goals of Cancer Therapy

The primary goals of cancer therapy include curing the disease, controlling tumor progression, and providing palliation for advanced cases to enhance quality of life.

Treatment of Cancer

Main Modalities

  • Surgery: Performing tumor excision where feasible to remove cancerous tissues.

  • Chemotherapy: Administers cytotoxic drugs aimed at rapidly dividing cells, with both cell-cycle specific and non-specific agents.

  • Targeted Therapy: Utilizes agents that specifically target molecular pathways involved in cancer growth.

  • Biotherapy/Immunotherapy: Aims to enhance the immune system's ability to fight cancer.

  • Radiation Therapy: Employs high-energy particles or waves to kill or damage cancer cells, available in internal (brachytherapy) and external forms.

Nursing Management

An interprofessional approach is essential in nursing management, emphasizing thorough patient education, effective symptom management, vigilant lab monitoring, and adherence to treatment protocols to improve patient outcomes.

Common Terminology Criteria for Adverse Events (CTCAE)

This grading system categorizes treatment-related toxicities from grade 1 (mild) to grade 5 (death), enabling healthcare providers to manage side effects effectively and safely, ensuring careful patient monitoring throughout the treatment process.